遠達環保(600292.SH):擬共同成立雲南遠達 投資3.24億元建設雲南玉溪項目
格隆匯6月4日丨遠達環保(600292.SH)公佈,公司全資子公司國家電投集團遠達環保催化劑有限公司(簡稱:催化劑公司)和國電投遠達生態能源有限公司(簡稱:生態能源公司)擬共同成立雲南遠達綜合智慧能源有限公司(簡稱:雲南遠達)作為項目實施主體,投資雲南省玉溪紅塔區100MWp户用側綜合智慧零碳電廠項目(簡稱:雲南玉溪項目)。項目總投資32,408.88萬元,資本金比例為20%,剩餘部分通過銀行貸款方式解決。雲南遠達註冊資本為7,000萬元,催化劑公司佔股51%,生態能源公司佔股49%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.